Related references
Note: Only part of the references are listed.The Movement Disorder Society Criteria for the Diagnosis of Multiple System Atrophy
Gregor K. Wenning et al.
MOVEMENT DISORDERS (2022)
Cerebrospinal fluid hemoglobin levels as markers of blood contamination: relevance for α-synuclein measurement
Silvia Paciotti et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2021)
LRRK2 along the Golgi and lysosome connection: a jamming situation
Giovanni Piccoli et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2021)
Scientific Perspectives: Structural Biology of LRRK2 and its Interaction with Microtubules
Andres E. Leschziner et al.
MOVEMENT DISORDERS (2021)
LRRK2 in Parkinson disease: challenges of clinical trials
Eduardo Tolosa et al.
NATURE REVIEWS NEUROLOGY (2020)
An Assessment of LRRK2 Serine 935 Phosphorylation in Human Peripheral Blood Mononuclear Cells in Idiopathic Parkinson?s Disease and G2019S LRRK2 Cohorts
Shalini Padmanabhan et al.
JOURNAL OF PARKINSONS DISEASE (2020)
Elevated In Vitro Kinase Activity in Peripheral Blood Mononuclear Cells ofLeucine-RichRepeat Kinase 2G2019SCarriers: A NovelEnzyme-LinkedImmunosorbent Assay-Based Method
Katerina Melachroinou et al.
MOVEMENT DISORDERS (2020)
From Synaptic Dysfunction to Neuroprotective Strategies in Genetic Parkinson's Disease: Lessons From LRRK2
Andrea Mancini et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2020)
Recent Developments in LRRK2-Targeted Therapy for Parkinson's Disease
Ye Zhao et al.
DRUGS (2019)
LRRK2-mediated Rab10 phosphorylation in immune cells from Parkinson's disease patients
Farzaneh Atashrazm et al.
MOVEMENT DISORDERS (2019)
Dopamine D2 receptor activation potently inhibits striatal glutamatergic transmission in a G2019S LRRK2 genetic model of Parkinson's disease
Alessandro Tozzi et al.
NEUROBIOLOGY OF DISEASE (2018)
Dopamine D2 receptor-mediated neuroprotection in a G2019S Lrrk2 genetic model of Parkinson's disease
Alessandro Tozzi et al.
CELL DEATH & DISEASE (2018)
LRRK2 activation in idiopathic Parkinson's disease
Roberto Di Maio et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Functional and behavioral consequences of Parkinson's disease-associated LRRK2-G2019S mutation
Deanna L. Benson et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2018)
Interrogating Parkinson's disease LRRK2 kinase pathway activity by assessing Rab10 phosphorylation in human neutrophils
Ying Fan et al.
BIOCHEMICAL JOURNAL (2018)
Diagnosis and management of dementia with Lewy bodies Fourth consensus report of the DLB Consortium
Ian G. McKeith et al.
NEUROLOGY (2017)
Elevated LRRK2 autophosphorylation in brain-derived and peripheral exosomes in LRRK2 mutation carriers
Shijie Wang et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2017)
LRRK2 mouse models: dissecting the behavior, striatal neurochemistry and neurophysiology of PD pathogenesis
Mattia Volta et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2017)
Ser(P)-1292 LRRK2 in urinary exosomes is elevated in idiopathic Parkinson's disease
Kyle B. Fraser et al.
MOVEMENT DISORDERS (2016)
Urinary LRRK2 phosphorylation predicts parkinsonian phenotypes in G2019S LRRK2 carriers
Kyle B. Fraser et al.
NEUROLOGY (2016)
MDS clinical diagnostic criteria for Parkinson's disease
Ronald B. Postuma et al.
MOVEMENT DISORDERS (2015)
LRRK2 and neuroinflammation: partners in crime in Parkinson's disease?
Isabella Russo et al.
JOURNAL OF NEUROINFLAMMATION (2014)
Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease
Mike A. Nalls et al.
NATURE GENETICS (2014)
LRRK2 secretion in exosomes is regulated by 14-3-3
Kyle B. Fraser et al.
HUMAN MOLECULAR GENETICS (2013)
Criteria for the diagnosis of corticobasal degeneration
Melissa J. Armstrong et al.
NEUROLOGY (2013)
Measurement of LRRK2 and Ser910/935 Phosphorylated LRRK2 in Peripheral Blood Mononuclear Cells from Idiopathic Parkinson's Disease Patients
Nicolas Dzamko et al.
JOURNAL OF PARKINSONS DISEASE (2013)
Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines
Irene Litvan et al.
MOVEMENT DISORDERS (2012)
Ser1292 Autophosphorylation Is an Indicator of LRRK2 Kinase Activity and Contributes to the Cellular Effects of PD Mutations
Zejuan Sheng et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Autophosphorylation in the Leucine-Rich Repeat Kinase 2 (LRRK2) GTPase Domain Modifies Kinase and GTP-Binding Activities
Philip J. Webber et al.
JOURNAL OF MOLECULAR BIOLOGY (2011)
The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson's disease
Mark R. Cookson
NATURE REVIEWS NEUROSCIENCE (2010)
Genome-wide association study reveals genetic risk underlying Parkinson's disease
Javier Simon-Sanchez et al.
NATURE GENETICS (2009)
A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking
C. E. Teunissen et al.
NEUROLOGY (2009)
Clinical diagnostic criteria for dementia associated with Parkinson's disease
Murat Emre et al.
MOVEMENT DISORDERS (2007)
Parkinson's disease-associated mutations in LRRK2 link enhanced GTP-binding and kinase activities to neuronal toxicity
Andrew B. West et al.
HUMAN MOLECULAR GENETICS (2007)
Share Paper
